A Study of Trastuzumab and Pyrotinib in HER2 Positive Locally Advanced or Metastatic Urothelial Carcinoma
Clinical trial NCT05318339 · UNKNOWN
Trial details
- NCT number
- NCT05318339
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-10
- Primary completion
- 2024-03-10
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.